VALPROIC ACID Drug Patent Profile
✉ Email this page to a colleague
When do Valproic Acid patents expire, and when can generic versions of Valproic Acid launch?
Valproic Acid is a drug marketed by Bionpharma, Catalent, Hibrow Hlthcare, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Upsher Smith Labs, Ani Pharms, Chartwell Rx, Hikma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Pharmobedient Cnsltg, and Quagen. and is included in fifteen NDAs.
The generic ingredient in VALPROIC ACID is valproic acid. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Valproic Acid
A generic version of VALPROIC ACID was approved as valproic acid by CATALENT on October 29th, 1991.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VALPROIC ACID?
- What are the global sales for VALPROIC ACID?
- What is Average Wholesale Price for VALPROIC ACID?
Summary for VALPROIC ACID
US Patents: | 0 |
Applicants: | 15 |
NDAs: | 15 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 144 |
Clinical Trials: | 189 |
Patent Applications: | 3,740 |
Drug Prices: | Drug price information for VALPROIC ACID |
DailyMed Link: | VALPROIC ACID at DailyMed |
Recent Clinical Trials for VALPROIC ACID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sohag University | Phase 2/Phase 3 |
Dr Cipto Mangunkusumo General Hospital | Phase 4 |
Wayne State University | Phase 4 |
Pharmacology for VALPROIC ACID
Drug Class | Anti-epileptic Agent Mood Stabilizer |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for VALPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for VALPROIC ACID
US Patents and Regulatory Information for VALPROIC ACID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bionpharma | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 073484-001 | Jun 29, 1993 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upsher Smith Labs | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 070631-001 | Jun 11, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Par Pharm | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 070431-001 | Feb 28, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | VALPROIC ACID | valproic acid | SYRUP;ORAL | 077105-001 | Jul 29, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |